A bone-saving drug could help breast cancer patients too – with less side effects
Cancer Breast Cancer osteoporosis

A bone-saving drug could help breast cancer patients too – with less side effects

Flávia Oliveira Geraldes
Flávia Oliveira Geraldes

In 10 seconds? Animal experiments have shown that a previously approved osteoporosis drug could be used to treat a subset of breast cancer, potentially with fewer side-effects than the current treatments.

What drug is that? It is a compound called lasofoxifene, which was developed for postmenopausal women to prevent the condition that makes bones brittle and break easily. Some non-pharmacological approaches (such as a diet rich in calcium and vitamin D and possibly some forms of exercise) might help prevent osteoporosis, but because some risk factors are non-modifiable (eg, older age and being female), there is still a need for pharmaceutical treatments for this disease, and that is why lasofoxifene was developed.

Get unlimited access to our 3-min Digests and other premium features!

Choose your plan.

Sparrow Insiders

$0 (Limited Offer)
  • Receive our daily Digest in your inbox
  • Created & reviewed by real scientists
  • Preview 380+ Digests in our library
  • Upgrade for unlimited learning
  • Unsubscribe anytime
  • Subject to availability
Join our first 25k subscribers for free! Signup Progress Bar Subscribe now for free

Sparrow Unlimited

$19 / month
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now

Sparrow Unlimited

$99 / year
  • One easy payment - save 56%
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now